New Frontiers in the Treatment of DMD Across the Age Spectrum
The France Foundation
New Frontiers in the Treatment of DMD Across the Age Spectrum
36:44
Key Clinical Trial Data on Current and Emerging Therapeutic Approaches: ICI and TKI for nccRCC
The France Foundation
Key Clinical Trial Data on Current and Emerging Therapeutic Approaches: ICI and TKI for nccRCC
34:23
Complexities in the Diagnosis of nccRCC: How Can We Do Better?
The France Foundation
Complexities in the Diagnosis of nccRCC: How Can We Do Better?
46:56
Myotonic Dystrophy Type 1: Mechanism of Disease
The France Foundation
Myotonic Dystrophy Type 1: Mechanism of Disease
1:37
Myotonic Dystrophy Type 1 (DM1) - Considerations for Exercise Management Discussion (Video 4/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Considerations for Exercise Management Discussion (Video 4/4)
5:42
Myotonic Dystrophy Type 1 (DM1) - Multidisciplinary Care Panel Discussion (Video 3/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Multidisciplinary Care Panel Discussion (Video 3/4)
4:29
Myotonic Dystrophy Type 1 (DM1) - Improving Diagnosis Panel Discussion (Video 2/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Improving Diagnosis Panel Discussion (Video 2/4)
4:32
Myotonic Dystrophy Type 1 (DM1) - Disease Overview Panel Discussion (Video 1/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Disease Overview Panel Discussion (Video 1/4)
5:52
Importance of a Multidisciplinary Patient-Centered Approach for Optimizing Care of People With HCC
The France Foundation
Importance of a Multidisciplinary Patient-Centered Approach for Optimizing Care of People With HCC
56:55
Symposium A New Era for Hemophilia Treatment Common Goals, Unique Perspectives
The France Foundation
Symposium A New Era for Hemophilia Treatment Common Goals, Unique Perspectives
1:58:25
The Critical Role of the Radiologist in the Diagnosis of Bronchiectasis
The France Foundation
The Critical Role of the Radiologist in the Diagnosis of Bronchiectasis
36:39
Immunotherapy in the Management of Advanced Biliary Tract Cancer (BTC)
The France Foundation
Immunotherapy in the Management of Advanced Biliary Tract Cancer (BTC)
36:23
Emerging Evidence on Immunotherapy for HCC Management in Early Stages
The France Foundation
Emerging Evidence on Immunotherapy for HCC Management in Early Stages
1:01:41
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
The France Foundation
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
57:08
Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages
The France Foundation
Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages
59:48
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
The France Foundation
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
57:08
Considering a Comprehensive Approach for Bronchiectasis Management
The France Foundation
Considering a Comprehensive Approach for Bronchiectasis Management
55:01
Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC
The France Foundation
Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC
36:05
Cognitive Impairment Associated with Schizophrenia
The France Foundation
Cognitive Impairment Associated with Schizophrenia
1:01:06
Negative and Cognitive Symptoms A Focus on Digital Therapeutics
The France Foundation
Negative and Cognitive Symptoms A Focus on Digital Therapeutics
32:47
Caring for Your Patients with ATTR
The France Foundation
Caring for Your Patients with ATTR
57:04
Expert Perspectives The Role of Immunotherapy in Advancing the Treatment of HCC and BTC
The France Foundation
Expert Perspectives The Role of Immunotherapy in Advancing the Treatment of HCC and BTC
1:08:08
Cleveland Clinic Tall Rounds: Treating Confirmed ATTR
The France Foundation
Cleveland Clinic Tall Rounds: Treating Confirmed ATTR
59:35
Weight Management in Community Health: Bridging Systems & Care Coordination
The France Foundation
Weight Management in Community Health: Bridging Systems & Care Coordination
1:08:27
Contemporary Strategies: Diagnosing ATTR Amyloidosis
The France Foundation
Contemporary Strategies: Diagnosing ATTR Amyloidosis
1:01:59
Improving the Diagnosis and Management of PFF: A Focus on SSc-ILD and IPF
The France Foundation
Improving the Diagnosis and Management of PFF: A Focus on SSc-ILD and IPF
42:33
Improving the Management of Patients with DMD: Emerging Evidence & Treatment Strategies
The France Foundation
Improving the Management of Patients with DMD: Emerging Evidence & Treatment Strategies
40:04
RSV Illness at Risk Populations
The France Foundation
RSV Illness at Risk Populations
8:44
RSV Illness Resource Use and Cost Burdens for Older Adults
The France Foundation
RSV Illness Resource Use and Cost Burdens for Older Adults
6:18
RSV Illness Vaccination Benefits
The France Foundation
RSV Illness Vaccination Benefits
9:30
What do you Know About RSV in Adults
The France Foundation
What do you Know About RSV in Adults
3:19
Yes, it Happens RSV Illness in Adults
The France Foundation
Yes, it Happens RSV Illness in Adults
31:57
RSV vs Influenza in Hospitalized Adults ≥ 60 years Old
The France Foundation
RSV vs Influenza in Hospitalized Adults ≥ 60 years Old
8:39
Addressing DMD Time to Diagnosis - Impact of Early Diagnosis
The France Foundation
Addressing DMD Time to Diagnosis - Impact of Early Diagnosis
8:06
Screening for, Assessing, and Diagnosing DMD
The France Foundation
Screening for, Assessing, and Diagnosing DMD
6:57
Addressing DMD Time to Diagnosis - Obstacles to Diagnosis
The France Foundation
Addressing DMD Time to Diagnosis - Obstacles to Diagnosis
7:17
Addressing DMD Time to Diagnosis - First Clinical Suspicion
The France Foundation
Addressing DMD Time to Diagnosis - First Clinical Suspicion
6:53
Addressing DMD Time to Diagnosis - Newborn Screening for DMD
The France Foundation
Addressing DMD Time to Diagnosis - Newborn Screening for DMD
5:26
Addressing DMD Time to Diagnosis - The Role of Genetic Testing for Diagnosing DMD
The France Foundation
Addressing DMD Time to Diagnosis - The Role of Genetic Testing for Diagnosing DMD
4:26
Complications of Duchenne Muscular Dystrophy
The France Foundation
Complications of Duchenne Muscular Dystrophy
10:23
Addressing DMD Time to Diagnosis - Consequences of Delayed Diagnosis
The France Foundation
Addressing DMD Time to Diagnosis - Consequences of Delayed Diagnosis
5:11
Multidisciplinary Management of Duchenne Muscular Dystrophy
The France Foundation
Multidisciplinary Management of Duchenne Muscular Dystrophy
6:33
Logistical Considerations for Long-term Care of Patients With Duchenne Muscular Dystrophy
The France Foundation
Logistical Considerations for Long-term Care of Patients With Duchenne Muscular Dystrophy
6:49
The Role of the Primary Care Provider in Duchenne Muscular Dystrophy
The France Foundation
The Role of the Primary Care Provider in Duchenne Muscular Dystrophy
6:51
Recognizing the Signs and Symptopms of Duchenne Muscular Dystrophy
The France Foundation
Recognizing the Signs and Symptopms of Duchenne Muscular Dystrophy
9:16
PNH Animation - The Complement System and PNH Pathophysiology
The France Foundation
PNH Animation - The Complement System and PNH Pathophysiology
5:06
PNH Animation - Therapies Targeting Complement Pathways in PNH
The France Foundation
PNH Animation - Therapies Targeting Complement Pathways in PNH
5:45
Hemophilia AAV Gene Therapy Animation
The France Foundation
Hemophilia AAV Gene Therapy Animation
2:25
Evolutions in the Management of Duchenne Muscular Dystrophy: Case Discussion
The France Foundation
Evolutions in the Management of Duchenne Muscular Dystrophy: Case Discussion
8:57
Evolutions in the Management of Duchenne Muscular Dystrophy: Therapies for DMD
The France Foundation
Evolutions in the Management of Duchenne Muscular Dystrophy: Therapies for DMD
29:01
Evolutions in the Management of Duchenne Muscular Dystrophy: Introduction to Dystrophin
The France Foundation
Evolutions in the Management of Duchenne Muscular Dystrophy: Introduction to Dystrophin
6:42
GLP 1 RAs Real World Patient Care Strategies for Type 2
The France Foundation
GLP 1 RAs Real World Patient Care Strategies for Type 2
50:57
Living with MS - Patient Needs at Diagnosis
The France Foundation
Living with MS - Patient Needs at Diagnosis
2:28
Living with MS - A Discussion Between a Physician and Patient on Selecting Treatment Options
The France Foundation
Living with MS - A Discussion Between a Physician and Patient on Selecting Treatment Options
2:59
Living with MS - Patient Needs at Diagnosis
The France Foundation
Living with MS - Patient Needs at Diagnosis
2:48
Multimodal Management of OUD (Animation 2 of 2)
The France Foundation
Multimodal Management of OUD (Animation 2 of 2)
1:50
Educating a Patient About Multimodal Pain (Animation 1 of 2)
The France Foundation
Educating a Patient About Multimodal Pain (Animation 1 of 2)
1:52
Advances in Nonvalvular Atrial Fibrillation: Exploring Undiagnosed NVAF and Comorbidities
The France Foundation
Advances in Nonvalvular Atrial Fibrillation: Exploring Undiagnosed NVAF and Comorbidities
22:57
Insights Into Advances in Nonvalvular Atrial Fibrillation: Enhancing NVAF Recognition
The France Foundation
Insights Into Advances in Nonvalvular Atrial Fibrillation: Enhancing NVAF Recognition
18:13
Insights Into Advances in Nonvalvular Atrial Fibrillation: Creating Patient-centric Treatment Plans
The France Foundation
Insights Into Advances in Nonvalvular Atrial Fibrillation: Creating Patient-centric Treatment Plans
34:24
The Patient Perspective Continuous Glucose Monitoring CGMs
The France Foundation
The Patient Perspective Continuous Glucose Monitoring CGMs
32:23
Relapse, Progression, and Treatment of the Patient with MS
The France Foundation
Relapse, Progression, and Treatment of the Patient with MS
56:04
The Role of B Cells in Progressive MS and the Long term Effects of B Cell Depletion
The France Foundation
The Role of B Cells in Progressive MS and the Long term Effects of B Cell Depletion
23:30
Biomarker Strategies for Lysosomal Diseases
The France Foundation
Biomarker Strategies for Lysosomal Diseases
18:08
GLP 1 RAs Real World Patient Care Strategies for Type 2
The France Foundation
GLP 1 RAs Real World Patient Care Strategies for Type 2
50:57
A Changing Conversation Delaying T1D Onset
The France Foundation
A Changing Conversation Delaying T1D Onset
44:02
Don't Delay, Check a CK: Early Diagnosis for Patients with DMD
The France Foundation
Don't Delay, Check a CK: Early Diagnosis for Patients with DMD
3:31
Multi-Disciplinary Care for Ambulatory versus Non-ambulatory patients with DMD
The France Foundation
Multi-Disciplinary Care for Ambulatory versus Non-ambulatory patients with DMD
2:14
Ongoing Role of Primary Care Providers in DMD Management
The France Foundation
Ongoing Role of Primary Care Providers in DMD Management
1:56
Early Screening and Therapeutic Options for Patients with DMD
The France Foundation
Early Screening and Therapeutic Options for Patients with DMD
3:02
I Have DMD: Am I a Candidate for Gene Therapy?
The France Foundation
I Have DMD: Am I a Candidate for Gene Therapy?
1:05
Managing Caregiving Expectations for Patients with DMD
The France Foundation
Managing Caregiving Expectations for Patients with DMD
1:22
How Does Gene Therapy Work for Patients with Duchenne Muscular Dystrophy?
The France Foundation
How Does Gene Therapy Work for Patients with Duchenne Muscular Dystrophy?
1:44
Managing Amyloidosis What You Need to Know Now and For the Future
The France Foundation
Managing Amyloidosis What You Need to Know Now and For the Future
1:00:52
The Delicate Balance of Brain Cholesterol: Animation 2 of 2
The France Foundation
The Delicate Balance of Brain Cholesterol: Animation 2 of 2
3:48
The Delicate Balance of Brain Cholesterol: Animation 1 of 2
The France Foundation
The Delicate Balance of Brain Cholesterol: Animation 1 of 2
3:15
Fall 2023 Conference Coverage: AAV Shedding
The France Foundation
Fall 2023 Conference Coverage: AAV Shedding
2:02
The Delicate Balance of Brain Cholesterol - TFF Satellite Symposium at AES 2023 Annual Meeting
The France Foundation
The Delicate Balance of Brain Cholesterol - TFF Satellite Symposium at AES 2023 Annual Meeting
2:12:06
Fall 2023 Conference Coverage: Impact of Combination Therapies for Neuromuscular Disorders
The France Foundation
Fall 2023 Conference Coverage: Impact of Combination Therapies for Neuromuscular Disorders
4:02
Fall 2023 Conference Coverage: Heterogeneity in Muscular Dystrophies
The France Foundation
Fall 2023 Conference Coverage: Heterogeneity in Muscular Dystrophies
4:57
Fall 2023 Conference Coverage: Registries and Natural History Studies
The France Foundation
Fall 2023 Conference Coverage: Registries and Natural History Studies
4:53
Fall 2023 Conference Coverage: Updates in Duchenne Muscular Dystrophy
The France Foundation
Fall 2023 Conference Coverage: Updates in Duchenne Muscular Dystrophy
4:59
Fall 2023 Conference Coverage: Functional Biomarkers for Muscular Dystrophy
The France Foundation
Fall 2023 Conference Coverage: Functional Biomarkers for Muscular Dystrophy
5:10
Fall 2023 Conference Coverage: Upcoming Therapies for LGMD
The France Foundation
Fall 2023 Conference Coverage: Upcoming Therapies for LGMD
3:09
Genetic Subtypes of LGMD - Animation
The France Foundation
Genetic Subtypes of LGMD - Animation
1:27
Limb Girdle Muscular Distrophy (LGMD) AAV Gene Therapy Animation
The France Foundation
Limb Girdle Muscular Distrophy (LGMD) AAV Gene Therapy Animation
2:29
Re-engaging Limb Girdle Muscular Distrophy (LGMD) Patients Into Care
The France Foundation
Re-engaging Limb Girdle Muscular Distrophy (LGMD) Patients Into Care
4:39
Preliminary Report on Gene Therapy for SGCB
The France Foundation
Preliminary Report on Gene Therapy for SGCB
0:51
Importance of Early Diagnosis in Limb Girdle Muscular Distrophy (LGMD)
The France Foundation
Importance of Early Diagnosis in Limb Girdle Muscular Distrophy (LGMD)
2:43
Accessibility of Genetic Testing Programs for Limb Girdle Muscular Distrophy (LGMD)
The France Foundation
Accessibility of Genetic Testing Programs for Limb Girdle Muscular Distrophy (LGMD)
0:33
LGMD Patient Resources
The France Foundation
LGMD Patient Resources
0:24
Limb-Girdle Muscular Dystrophy (LGMD): Natural History
The France Foundation
Limb-Girdle Muscular Dystrophy (LGMD): Natural History
4:07
Duchenne Muscular Dystrophy (DMD): Gene Therapy and How Muscle Responds
The France Foundation
Duchenne Muscular Dystrophy (DMD): Gene Therapy and How Muscle Responds
2:32
Limb-Girdle Muscular Dystrophy (LGMD): Diagnostic Algorithm
The France Foundation
Limb-Girdle Muscular Dystrophy (LGMD): Diagnostic Algorithm
5:03
Limb-Girdle Muscular Dystrophy: Which Gene Causes Which LGMD?
The France Foundation
Limb-Girdle Muscular Dystrophy: Which Gene Causes Which LGMD?
3:25
Duchenne Muscular Dystrophy (DMD) Treatment: The Bubble
The France Foundation
Duchenne Muscular Dystrophy (DMD) Treatment: The Bubble
2:45
Duchenne Muscular Dystrophy (DMD): Gene Therapy and Families
The France Foundation
Duchenne Muscular Dystrophy (DMD): Gene Therapy and Families
3:20
Providing a Medical Home for Kids with Rare Lung Disease: Recognizing and Caring for Kids
The France Foundation
Providing a Medical Home for Kids with Rare Lung Disease: Recognizing and Caring for Kids
1:19:54
Biomarker Driven Treatment of Metastatic Colorectal Cancer
The France Foundation
Biomarker Driven Treatment of Metastatic Colorectal Cancer
44:47
Stroke Prevention Through Afib Recognition and Treatment
The France Foundation
Stroke Prevention Through Afib Recognition and Treatment
41:01
A Spotlight on Rett Syndrome: Delayed Diagnosis, Patient/Caregiver Perspectives & Evolving Treatment
The France Foundation
A Spotlight on Rett Syndrome: Delayed Diagnosis, Patient/Caregiver Perspectives & Evolving Treatment
40:38
Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Multidisciplinary Collaboration
The France Foundation
Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Multidisciplinary Collaboration
3:02
Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Delay in Diagnosis - Why?
The France Foundation
Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Delay in Diagnosis - Why?
9:22
Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Presentation in Pregnancy
The France Foundation
Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Presentation in Pregnancy
2:27
Practical Considerations for DMD Management in the Era of Gene Therapy
The France Foundation
Practical Considerations for DMD Management in the Era of Gene Therapy
43:27
Strategies to Reduce Health Disparities and Improve Outcomes in Breast Cancer Treatment
The France Foundation
Strategies to Reduce Health Disparities and Improve Outcomes in Breast Cancer Treatment
39:57
Strategies to Reduce Health Disparities and Improve Outcomes in Prostate Cancer Treatment
The France Foundation
Strategies to Reduce Health Disparities and Improve Outcomes in Prostate Cancer Treatment
7:52
Treating Hepatocellular Carcinoma Cases with Locoregional and Systemic Therapies
The France Foundation
Treating Hepatocellular Carcinoma Cases with Locoregional and Systemic Therapies
1:07:23
Evolving Systemic Treatments for Hepatocellular Carcinoma: Multidisciplinary Strategies
The France Foundation
Evolving Systemic Treatments for Hepatocellular Carcinoma: Multidisciplinary Strategies
42:29
Amyloidosis - Seeing the Forest for the Trees
The France Foundation
Amyloidosis - Seeing the Forest for the Trees
1:02:29
Evolving Options for the Treatment of HCC With Immunotherapy and Liver Directed Therapy (LDT)
The France Foundation
Evolving Options for the Treatment of HCC With Immunotherapy and Liver Directed Therapy (LDT)
28:59
Delayed Diagnosis of SSc ILD with PPF
The France Foundation
Delayed Diagnosis of SSc ILD with PPF
20:00
Identifying the Signs and Symptoms of PFF Case01
The France Foundation
Identifying the Signs and Symptoms of PFF Case01
13:05
SSc ILD With Rapid Progression
The France Foundation
SSc ILD With Rapid Progression
14:25
The Role of the Community Radiologist in the Care Coordination of Patients With ILDs
The France Foundation
The Role of the Community Radiologist in the Care Coordination of Patients With ILDs
52:30
The Radiologist's Role in the Multidisciplinary Management of Bronchiectasis
The France Foundation
The Radiologist's Role in the Multidisciplinary Management of Bronchiectasis
27:48
Recognizing Bias and Health Care Disparities in Black Patients (Case 2 of 2)
The France Foundation
Recognizing Bias and Health Care Disparities in Black Patients (Case 2 of 2)
5:09
Recognizing Bias and Health Care Disparities in Black Patients (Case 1 of 2)
The France Foundation
Recognizing Bias and Health Care Disparities in Black Patients (Case 1 of 2)
3:30
NTM-LD Improving Diagnosis Individualized Treatment and Adherence
The France Foundation
NTM-LD Improving Diagnosis Individualized Treatment and Adherence
36:15
DMD and Gene Therapy What's On the Horizon
The France Foundation
DMD and Gene Therapy What's On the Horizon
32:39
Multiple Sclerosis (MS) Case and Animation - Considerations to Encourage Patient Engagement
The France Foundation
Multiple Sclerosis (MS) Case and Animation - Considerations to Encourage Patient Engagement
24:56
The Burden of Bronchiectasis A Focus on Non Cystic Fibrosis Bronchiectasis
The France Foundation
The Burden of Bronchiectasis A Focus on Non Cystic Fibrosis Bronchiectasis
45:12
Fabry Disease: Currently Approved Therapies and Monitoring Response
The France Foundation
Fabry Disease: Currently Approved Therapies and Monitoring Response
4:07
Fabry Disease: Diagnosing Women
The France Foundation
Fabry Disease: Diagnosing Women
3:01
Fabry Disease: Objective and Subjective Measurements of Treatment Response
The France Foundation
Fabry Disease: Objective and Subjective Measurements of Treatment Response
3:57
Fabry Disease: Importance of Early Interventions
The France Foundation
Fabry Disease: Importance of Early Interventions
1:32
Treating Women Who Have Fabry Disease
The France Foundation
Treating Women Who Have Fabry Disease
1:14
Fabry Disease: Genetic Counseling
The France Foundation
Fabry Disease: Genetic Counseling
3:31
Fabry Disease in Women
The France Foundation
Fabry Disease in Women
1:15
Fabry Disease in Pregnancy
The France Foundation
Fabry Disease in Pregnancy
4:41
Women, Social Dynamics, and Fabry Treatment
The France Foundation
Women, Social Dynamics, and Fabry Treatment
3:22
Symptoms and Diagnosis of Fabry Disease in Females
The France Foundation
Symptoms and Diagnosis of Fabry Disease in Females
3:58
Chaperone Therapy: How It Works and When to Use It
The France Foundation
Chaperone Therapy: How It Works and When to Use It
2:09
Fabry Disease in Females
The France Foundation
Fabry Disease in Females
2:57
Fabry Disease: The Difference for Males and Females
The France Foundation
Fabry Disease: The Difference for Males and Females
2:35
Fabry Disease: Why is Early Diagnosis Important?
The France Foundation
Fabry Disease: Why is Early Diagnosis Important?
2:37
Fabry Disease: Challenges in Diagnosis
The France Foundation
Fabry Disease: Challenges in Diagnosis
5:01
A Holistic Approach to Patient Care for Muscular Dystrophy
The France Foundation
A Holistic Approach to Patient Care for Muscular Dystrophy
3:29
Comparing Gene Therapies Across Programs
The France Foundation
Comparing Gene Therapies Across Programs
4:53
Is Newborn Screening Feasible for DMD or LGMD
The France Foundation
Is Newborn Screening Feasible for DMD or LGMD
5:12
Getting Prepared for Gene Transfer Therapy
The France Foundation
Getting Prepared for Gene Transfer Therapy
5:02
Sharing Clinical Trial Results With Patients
The France Foundation
Sharing Clinical Trial Results With Patients
3:09
Updates in Safety and Efficacy of Gene Therapy for DMD
The France Foundation
Updates in Safety and Efficacy of Gene Therapy for DMD
4:01
Lessons Learned from SMA for LGMD
The France Foundation
Lessons Learned from SMA for LGMD
2:29
Lessons Learned from SMA for DMD
The France Foundation
Lessons Learned from SMA for DMD
2:58
Importance of Assessments in DMD
The France Foundation
Importance of Assessments in DMD
4:10
Practical Considerations in Administering Gene Therapy
The France Foundation
Practical Considerations in Administering Gene Therapy
6:35
Importance of Genetic Diagnosis for LGMD
The France Foundation
Importance of Genetic Diagnosis for LGMD
4:31
Many Genes Make Gene Therapy Challenging for LGMD
The France Foundation
Many Genes Make Gene Therapy Challenging for LGMD
6:18
Impact of New Therapies for Patients with DMD
The France Foundation
Impact of New Therapies for Patients with DMD
4:38
Excitement Around New Therapies for DMD
The France Foundation
Excitement Around New Therapies for DMD
3:48
DOAC-Related Bleeding
The France Foundation
DOAC-Related Bleeding
1:16:22
Immune Checkpoint Inhibitors and RCC: Where Are We Now?
The France Foundation
Immune Checkpoint Inhibitors and RCC: Where Are We Now?
52:18
Gene Therapy and the Future of DMD: A Summary
The France Foundation
Gene Therapy and the Future of DMD: A Summary
2:34
Gene Therapy and the Future of DMD: Goals of Treatment
The France Foundation
Gene Therapy and the Future of DMD: Goals of Treatment
4:25
Gene Therapy and the Future of DMD: Anti-Transgene Reactions
The France Foundation
Gene Therapy and the Future of DMD: Anti-Transgene Reactions
1:53
Pneumococcal Vaccine Resources for Health Care Providers
The France Foundation
Pneumococcal Vaccine Resources for Health Care Providers
2:07
Pneumococcal Vaccine The SHARE Model
The France Foundation
Pneumococcal Vaccine The SHARE Model
3:13
Pneumococcal Vaccine Implementation Strategies
The France Foundation
Pneumococcal Vaccine Implementation Strategies
5:36
Pneumococcal Vaccination - New vaccines Recommendations
The France Foundation
Pneumococcal Vaccination - New vaccines Recommendations
2:58
Pneumococcal Vaccine Resources For Your Team
The France Foundation
Pneumococcal Vaccine Resources For Your Team
2:42
Pneumococcal Vaccine Resources For Your Patients
The France Foundation
Pneumococcal Vaccine Resources For Your Patients
2:14
The Role of Pediatricians in Managing Patients with DMD
The France Foundation
The Role of Pediatricians in Managing Patients with DMD
4:13
Don't Delay Two-Prong Approach (DMD)
The France Foundation
Don't Delay Two-Prong Approach (DMD)
6:47
Clinician's Perspective on How to Assess a Patient for DMD
The France Foundation
Clinician's Perspective on How to Assess a Patient for DMD
4:13
How History Can Inform a DMD Diagnosis
The France Foundation
How History Can Inform a DMD Diagnosis
4:51
Early Signs of DMD
The France Foundation
Early Signs of DMD
5:13
New CDC Guidelines Encourage More Frequent Milestone Screenings
The France Foundation
New CDC Guidelines Encourage More Frequent Milestone Screenings
8:54
Assessing Motor Function in Duchenne Muscular Dystrophy (DMD)
The France Foundation
Assessing Motor Function in Duchenne Muscular Dystrophy (DMD)
2:05
Diagnostic Algorithm for Spinal Muscular Atrophy (SMA)
The France Foundation
Diagnostic Algorithm for Spinal Muscular Atrophy (SMA)
2:44
Critical Importance of Early Diagnosis of Patients with Spinal Muscular Atrophy (SMA)
The France Foundation
Critical Importance of Early Diagnosis of Patients with Spinal Muscular Atrophy (SMA)
1:53
Four or More Copies of SMN2 in Patients with Spinal Muscular Atrophy: Treat or Wait?
The France Foundation
Four or More Copies of SMN2 in Patients with Spinal Muscular Atrophy: Treat or Wait?
1:59
The Changing Phenotype of Spinal Muscular Atrophy With Treatment
The France Foundation
The Changing Phenotype of Spinal Muscular Atrophy With Treatment
3:09
Newborn Screening Treatment Algorithm for Patients with Spinal Muscular Atrophy (SMA)
The France Foundation
Newborn Screening Treatment Algorithm for Patients with Spinal Muscular Atrophy (SMA)
1:43
Role of the Multidisciplinary Team in the Management of Patients with Spinal Muscular Atrophy (SMA)
The France Foundation
Role of the Multidisciplinary Team in the Management of Patients with Spinal Muscular Atrophy (SMA)
4:05
Ongoing Role of Pediatrician in DMD Management
The France Foundation
Ongoing Role of Pediatrician in DMD Management
6:46
Diagnosing DMD in Rural Areas
The France Foundation
Diagnosing DMD in Rural Areas
3:20
When Should We Be Testing for DMD?
The France Foundation
When Should We Be Testing for DMD?
3:51
Screening for DMD: What Should We Be Looking For?
The France Foundation
Screening for DMD: What Should We Be Looking For?
5:48
Obstacles to Diagnosing DMD in the Pediatric Patient
The France Foundation
Obstacles to Diagnosing DMD in the Pediatric Patient
6:23
DMD Gene Therapy Clinical Trials
The France Foundation
DMD Gene Therapy Clinical Trials
5:09
Biomarkers Versus Functional Assessment Debate (DMD)
The France Foundation
Biomarkers Versus Functional Assessment Debate (DMD)
3:27
Triglycerides: Clinical Impact and Recommendations for Reduction
The France Foundation
Triglycerides: Clinical Impact and Recommendations for Reduction
2:25
Measuring Waist Circumference
The France Foundation
Measuring Waist Circumference
1:27
Novel Approaches to Motor Function Assessment in Duchenne Muscular Dystrophy
The France Foundation
Novel Approaches to Motor Function Assessment in Duchenne Muscular Dystrophy
3:09
Overview of WMS Conference
The France Foundation
Overview of WMS Conference
5:47
Multidisciplinary Approach to DMD Management
The France Foundation
Multidisciplinary Approach to DMD Management
3:38
Future of DMD Gene Therapy
The France Foundation
Future of DMD Gene Therapy
4:23
Immune Response to DMD Gene Therapy
The France Foundation
Immune Response to DMD Gene Therapy
7:51
Considerations for DMD Gene Transfer Therapy
The France Foundation
Considerations for DMD Gene Transfer Therapy
4:08
IMPACT - Impacting Multiple Myeloma Patients in African American Communities
The France Foundation
IMPACT - Impacting Multiple Myeloma Patients in African American Communities
3:48
Updated Pneumococcal Recommendations
The France Foundation
Updated Pneumococcal Recommendations
2:58
COVID-19: Identifying and Addressing Barriers to Appropriate Testing (Episode 6)
The France Foundation
COVID-19: Identifying and Addressing Barriers to Appropriate Testing (Episode 6)
7:43
COVID-19: Potential Drug-Drug Interactions, Side Effects, and Mitigation Options (Episode 10)
The France Foundation
COVID-19: Potential Drug-Drug Interactions, Side Effects, and Mitigation Options (Episode 10)
10:15
COVID-19: Return of COVID Symptoms/Seropositivity After Treatment (Episode 9)
The France Foundation
COVID-19: Return of COVID Symptoms/Seropositivity After Treatment (Episode 9)
6:12
COVID-19: What to Do and Where to Go Following a Positive COVID Test? (Episode 5)
The France Foundation
COVID-19: What to Do and Where to Go Following a Positive COVID Test? (Episode 5)
10:06
COVID-19: Pediatric MIS-C (Multi-Inflammatory Syndrome – Children) (Episode 2)
The France Foundation
COVID-19: Pediatric MIS-C (Multi-Inflammatory Syndrome – Children) (Episode 2)
11:39
COVID-19: Practical Recommendations for Isolating and Quarantining (Episode 1)
The France Foundation
COVID-19: Practical Recommendations for Isolating and Quarantining (Episode 1)
10:47
Changing the Phenotype of DMD
The France Foundation
Changing the Phenotype of DMD
4:51
New Data from Gene Therapy Clinical Trials in DMD
The France Foundation
New Data from Gene Therapy Clinical Trials in DMD
7:20